Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

OKB7 recognizes antigen on T-cell malignancies.

S Ahmed, M Saleem, S A Ahmed

    American Journal of Clinical Pathology
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Black Hole Spectroscopy and Tests of General Relativity with GW250114.

    Physical review letters·2026
    Same author

    GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

    Physical review letters·2025
    Same author

    Biomedical properties, characterization of seaweeds species and antimicrobial activity.

    Brazilian journal of biology = Revista brasleira de biologia·2024
    Same author

    Numerical investigation of entropy generation and Magnetohydronamic natural convection in a porous square cavity with four embedded cylinders.

    Heliyon·2024
    Same author

    A new anti-inflammatory lupane in <i>Ziziphus jujuba</i> (L.) Gaertn. var. <i>hysudrica</i> Edgew.

    Heliyon·2024
    Same author

    Uptake and impact of COVID-19 vaccination among HIV key populations: a cohort study from Tamil Nadu, India.

    Journal of rural medicine : JRM·2023

    The OKB7 antibody shows reactivity in some T-cell acute lymphoblastic leukemia (T-ALL) and B-cell chronic lymphocytic leukemia (B-CLL) cases. This suggests OKB7 may help identify specific T-ALL phenotypes, not just B-cell malignancies.

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Lymphoid malignancies encompass various hematological cancers.
    • Immunophenotyping is crucial for classifying lymphoid leukemias.
    • OKB7 is an antibody used in cell surface marker analysis.

    Purpose of the Study:

    • To investigate the reactivity pattern of the OKB7 antibody in lymphoid malignancies.
    • To determine if OKB7 is specific for B-cell lineage.
    • To explore the potential utility of OKB7 in identifying specific leukemia subtypes.

    Main Methods:

    • Analysis of OKB7 antibody expression in 49 cases of lymphoid malignancies.
    • Included cases of acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and hairy cell leukemia (HCL).

    Related Experiment Videos

  • Correlating OKB7 positivity with other markers like CALLA (Common Acute Lymphoblastic Leukemia Antigen).

    • Main Results:

    • OKB7 reacted with 4 out of 5 T-ALL cases and 8 out of 17 B-CLL cases.
    • All OKB7-positive T-ALL cases were also CALLA-positive.
    • Hairy cell leukemia and non-T-ALL cases did not react with OKB7.

    Conclusions:

    • OKB7 is not exclusively specific for B-lineage lymphoid cells.
    • Cross-reactivity with T-ALL cases was observed.
    • OKB7 may aid in identifying unique T-ALL phenotypes (T+, OKB7+, CALLA+).